[Systemic acne therapy].
Thielitz
Anja
A
Klinik für Dermatologie und Venerologie, Otto-von-Guericke-Universität Magdeburg. Anja.Thielitz@medizin.uni-magdeburg.de
Gollnick
Harald
H
D000152:Acne Vulgaris / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000726:Androgen Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017373:Cyproterone Acetate / Q000008:administration & dosage / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008911:Minocycline / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009824:Ointments; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012176:Retinoids / Q000008:administration & dosage / Q000627:therapeutic use; D013752:Tetracycline / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000726:Androgen Antagonists; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D007641:Keratolytic Agents; D009824:Ointments; D012176:Retinoids; D017373:Cyproterone Acetate; D011239:Prednisolone; D015474:Isotretinoin; D013752:Tetracycline; D008911:Minocycline; D004318:Doxycycline